2021-05-28_Interview_Stanislas_Veillet_Boursier_com

Interview with Stanislas Veillet on Boursier.com

Stanislas Veillet, CEO of Biophytis, analyses on BOURSIER.COM the new development cycle of Biophytis and reviews the clinical successes of the COVA, SARA, MYOCA and MACA studies which are in the Biophytis pipeline.